CG Oncology Inc.

CGON | NASDAQ

Price Alert Chart Builder DCF Calculator

$78.25

+$3.63 (+4.86%)

At close: Sep 21, 2026, 4:00 PM ET

$78.25

$0 (0.00%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $6.58B

Enterprise Value $5.88B

Beta 0.24

Average Volume 946.26K

Shares Outstanding (Diluted) 88.2M

Shares Change YoY 15.71%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US1569441009

Price Performance

Price Change 1M -1.3%

Price Change 3M 19.1%

Price Change 6M 18.9%

Price Change YTD 87.3%

Price Change 1Y 111.3%

Price Change 3Y 123.4%

Price Change 5Y 123.4%

1M CAGR (ann.) -0.3%

1Y CAGR (ann.) 97.8%

5Y CAGR (ann.) N/A

All-Time CAGR 30.1%

Valuation

PE Ratio -28.98

Forward PE N/A

PEG Ratio 0.73

Forward PEG 4.90

PS Ratio 1,108.20

Forward PS 85.60

PB Ratio 6.71

P/FCF Ratio -29.17

P/Adj. FCF Ratio -24.79

P/OCF Ratio -38.74

EV/Sales 944.51

EV/EBIT -26.22

EV/EBITDA -26.47

EV/FCF -24.86

Earnings Yield -3.5%

FCF Yield -3.4%

Adj. FCF Yield -4.0%

Financial Health

Net Cash $1.03B

Total Debt $8.82M

Cash & Short-Term Investments $1.03B

Total Assets $1.09B

Current Ratio 22.22

Quick Ratio 22.20

Debt / Equity Ratio 0.01

Debt / EBITDA -0.04

Debt / FCF -0.04

OCF / Debt -26.69

Interest Coverage 0.00

Altman Z-Score 69.61

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin -82.7%

Operating Profit Margin -4056.2%

EBITDA Margin -3568.9%

Net Profit Margin -3602.7%

FCF Margin -3798.8%

Adj. FCF Margin -4470.0%

SBC / Revenue 567.2%

SBC Impact (per share) -17.7%

Returns

Return on Assets -20.7%

Return on Equity -25.2%

Return on Invested Capital -24.3%

Return on Capital Employed -24.3%

Return on Tangible Assets -20.9%

Historical Growth (CAGR)

Revenue CAGR 3Y 217.8%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -42.7%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -62.9%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 10

EPS Growth Next 3Y 66.2%

Revenue Growth Next 3Y 430.8%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $87.20

Price Target Upside 11.4%

Cash Flow

Operating Cash Flow $-235.41M

Free Cash Flow $-236.59M

Adj. Free Cash Flow $-278.39M

FCF Per Share -$2.03

OCF Per Share -$2.02

OCF/S Ratio -2865.6%

Income Statement

Revenue $6.23M

Gross Profit $-5.15M

Operating Income $-252.62M

EBITDA $-222.27M

Net Income $-224.38M

EPS (Diluted) -$2.70

Revenue / Employee $43.86K

Profit / Employee $-1.58M

Employees 142